Moloney Securities Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$771K Sell
11,169
-6,289
-36% -$434K 0.1% 213
2025
Q1
$1.21M Buy
17,458
+7,661
+78% +$532K 0.16% 151
2024
Q4
$843K Sell
9,797
-1,011
-9% -$87K 0.11% 200
2024
Q3
$1.29M Sell
10,808
-4,103
-28% -$489K 0.17% 140
2024
Q2
$2.13M Buy
14,911
+1,970
+15% +$281K 0.31% 78
2024
Q1
$1.66M Buy
12,941
+827
+7% +$106K 0.25% 98
2023
Q4
$1.25M Sell
12,114
-50
-0.4% -$5.17K 0.2% 127
2023
Q3
$1.11M Sell
12,164
-600
-5% -$54.6K 0.2% 123
2023
Q2
$1.03M Buy
12,764
+102
+0.8% +$8.25K 0.18% 136
2023
Q1
$1.01M Sell
12,662
-2,254
-15% -$179K 0.19% 141
2022
Q4
$1.01M Sell
14,916
-346
-2% -$23.4K 0.22% 127
2022
Q3
$760K Sell
15,262
-2,100
-12% -$105K 0.18% 145
2022
Q2
$967K Sell
17,362
-400
-2% -$22.3K 0.23% 127
2022
Q1
$986K Buy
17,762
+262
+1% +$14.5K 0.19% 140
2021
Q4
$980K Sell
17,500
-400
-2% -$22.4K 0.17% 150
2021
Q3
$859K Sell
17,900
-3,300
-16% -$158K 0.16% 175
2021
Q2
$888K Hold
21,200
0.16% 158
2021
Q1
$715K Sell
21,200
-200
-0.9% -$6.75K 0.14% 170
2020
Q4
$747K Sell
21,400
-480
-2% -$16.8K 0.17% 153
2020
Q3
$760K Hold
21,880
0.2% 129
2020
Q2
$716K Sell
21,880
-670
-3% -$21.9K 0.21% 121
2020
Q1
$679K Sell
22,550
-400
-2% -$12K 0.24% 111
2019
Q4
$664K Hold
22,950
0.21% 136
2019
Q3
$593K Sell
22,950
-546
-2% -$14.1K 0.2% 134
2019
Q2
$600K Buy
23,496
+662
+3% +$16.9K 0.2% 136
2019
Q1
$597K Sell
22,834
-2,662
-10% -$69.6K 0.21% 138
2018
Q4
$587K Hold
25,496
0.24% 120
2018
Q3
$601K Buy
25,496
+200
+0.8% +$4.71K 0.21% 131
2018
Q2
$583K Sell
25,296
-4,300
-15% -$99.1K 0.22% 137
2018
Q1
$729K Sell
29,596
-2,800
-9% -$69K 0.3% 112
2017
Q4
$869K Sell
32,396
-4,800
-13% -$129K 0.37% 93
2017
Q3
$895K Sell
37,196
-1,354
-4% -$32.6K 0.4% 75
2017
Q2
$827K Buy
38,550
+2,000
+5% +$42.9K 0.41% 71
2017
Q1
$626K Sell
36,550
-18,756
-34% -$321K 0.32% 97
2016
Q4
$992K Buy
+55,306
New +$992K 0.6% 41